CytomX Therapeutics Inc (CTMX)
4.43
-0.07
(-1.56%)
USD |
NASDAQ |
May 03, 16:00
4.725
+0.30
(+6.66%)
Pre-Market: 08:30
CytomX Therapeutics Free Cash Flow: -56.88M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -56.88M |
| September 30, 2023 | -36.22M |
| June 30, 2023 | -52.22M |
| March 31, 2023 | -61.18M |
| December 31, 2022 | -112.53M |
| September 30, 2022 | -142.39M |
| June 30, 2022 | -138.10M |
| March 31, 2022 | -131.77M |
| December 31, 2021 | -120.64M |
| September 30, 2021 | -107.08M |
| June 30, 2021 | -102.56M |
| March 31, 2021 | 22.81M |
| December 31, 2020 | 2.95M |
| September 30, 2020 | -9.36M |
| June 30, 2020 | -7.851M |
| March 31, 2020 | -153.90M |
| December 31, 2019 | -143.98M |
| Date | Value |
|---|---|
| September 30, 2019 | -143.66M |
| June 30, 2019 | -126.31M |
| March 31, 2019 | -104.81M |
| December 31, 2018 | -79.31M |
| September 30, 2018 | -27.68M |
| June 30, 2018 | -26.87M |
| March 31, 2018 | 173.48M |
| December 31, 2017 | 168.81M |
| September 30, 2017 | 148.38M |
| June 30, 2017 | 139.13M |
| March 31, 2017 | -18.37M |
| December 31, 2016 | -4.208M |
| September 30, 2016 | -13.89M |
| June 30, 2016 | -6.977M |
| March 31, 2016 | -29.25M |
| December 31, 2015 | -29.01M |
Free Cash Flow Range, Past 5 Years
-153.90M
Minimum
Mar 2020
22.81M
Maximum
Mar 2021
-85.31M
Average
-107.08M
Median
Sep 2021
Free Cash Flow Benchmarks
| Ocular Therapeutix Inc | -76.32M |
| Bristol-Myers Squibb Co | 12.51B |
| ACADIA Pharmaceuticals Inc | -23.35M |
| Cytokinetics Inc | -415.75M |
| Calidi Biotherapeutics Inc | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.96M |
| Cash from Investing (Quarterly) | 12.87M |
| Cash from Financing (Quarterly) | 0.244M |
| Free Cash Flow Per Share (Quarterly) | -0.2726 |
| Free Cash Flow to Equity (Quarterly) | -22.23M |
| Free Cash Flow to Firm (Quarterly) | -22.23M |
| Free Cash Flow Yield | -17.39% |